US FDA Actively Reviewing Approval for Moderna COVID-19 Vaccine Booster Shot!!
Moderna Booster Shot Shows Enhanced Immune Efficacy Against Delta Variant, FDA Clinical Data Submitted!!
Following Nanocovax, even Moderna is a highly undervalued COVID vaccine beneficiary stock with a potential increase of 1000%! Check it before it's too late!
Check out the TOP 3 mRNA-related stocks that will benefit from the COVID-19 vaccine boom and click TOP 1 for information and response!
●TOP 3● Ilyang Pharmaceutical (094820): Pharmaceutical company with production facilities capable of manufacturing finished mRNA products. Annual production capacity of 1.4 billion doses attracting overseas love calls.
●TOP 2● ST Pharm (189860): News of participation in a consortium developing next-generation mRNA vaccine platforms and discovering mRNA vaccines targeting the Delta variant.
●TOP 1● (***0**) : Ultra-high surge imminent stock, limited to the first 10 people ★Free Disclosure★ ▶Click◀
★Bonus Hidden Stock★ This is it!! Also limited to the first 10 people ▶Check Stock◀
Only a few days left!! It's going up right away!! Hurry and grab it before it's too late!!
[Profit Status by Stock]
Doosan Heavy Industries +142% profit!
KEPCO Engineering & Construction +151% profit!
Bioneer +169% profit!
Mad Factory +308% profit!
ATECTN 130% profit!
Sang-A Frontec +121% profit!
[Today's Stocks of Interest]: Hankook Sunjae / Deokshin Housing / Kukjeon Pharmaceuticals / Orient Bio / Joil Aluminum
※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
